(NASDAQ: XBIO) Xenetic Biosciences's forecast annual revenue growth rate of -6.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Xenetic Biosciences's revenue in 2024 is $2,539,986.On average, 1 Wall Street analysts forecast XBIO's revenue for 2024 to be $4,159,847, with the lowest XBIO revenue forecast at $4,159,847, and the highest XBIO revenue forecast at $4,159,847. On average, 1 Wall Street analysts forecast XBIO's revenue for 2025 to be $2,773,231, with the lowest XBIO revenue forecast at $2,773,231, and the highest XBIO revenue forecast at $2,773,231.
In 2026, XBIO is forecast to generate $3,543,573 in revenue, with the lowest revenue forecast at $3,543,573 and the highest revenue forecast at $3,543,573.